Skip to main content
Premium Trial:

Request an Annual Quote

Roche and ParAllele Partner on Diabetes SNP Discovery

NEW YORK, Sept. 16 (GenomeWeb News) - Roche and ParAllele BioScience have begun a research collaboration to discover genes and genetic variations related to type 2 diabetes, the companies said today.

Under the terms of the collaboration, which will focus on identifying new drugs and diagnostics to for the disease, Roche will provide clinical samples and funding to support the study, while ParAllele will use its SNP discovery and SNP genotyping platforms to discover genetic variations in the samples that are most often associated with type 2 diabetes.

Roche plans to further evaluate associations found during the study in a variety of larger patient populations. The companies did not provide further details about the collaboration.

ParAllele, which has signed SNP-based research collaborations with Baylor College of Medicine and Merck, said that the Roche project is the first commercial study that combines its SNP discovery platforms with high-throughput genotyping.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.